January 19, 2024

Better access for women with breast cancer in Chaudière-Appalaches

The McPeak-Sirois Group, one of the largest clinical research consortiums in breast cancer in Canada, and the Centre Intégré en Santé et Services sociaux de Chaudière-Appalaches (CISSS-CA) will collaborate to enable people with breast cancer to have better access to clinical trials in the region.

This partnership is part of the Programme Accès-recherche Dr André-Robidoux of the McPeak-Sirois Group and is financially supported by Breast Cancer Canada. This program aims to give more people living in regions in Quebec access to clinical trials, which are cutting-edge treatments. Thanks to clinical research, it is possible to benefit from the most recent scientific advances and improve patients’ chances of survival as well as their quality of life.

“We are very proud to count the CISSS Chaudière-Appalaches as an affiliated member of our Group which now brings together 12 hospital centers across Quebec,” underlined Charles Sirois and Susan McPeak, Co-founders of the McPeak-Sirois Group.

“Today marks a pivotal moment in our united efforts to end breast cancer. Breast Cancer Canada proudly welcomes the CISSS de Chaudière-Appalaches as the 12th member of the McPeak-Sirois Group,” added Kimberly Carson, CEO of Breast Cancer Canada. “This new partnership strengthens our commitment to advancing clinical trials and ensuring greater access to the latest cutting-edge treatments. Together, we amplify our impact, bringing more personalized and progressive care to breast cancer patients.”

“I would like to welcome Dr Vincent Barrette to the Group’s Scientific Committee. For people in the Chaudière-Appalaches region, his commitment will result in significantly improved access to clinical research trials in breast cancer,” said Dr. Jamil Asselah, Chair of the Group’s Scientific Committee and Medical Oncologist at the MUHC.

“This association with the McPeak-Sirois Group will allow women with breast cancer from Chaudière-Appalaches to participate in clinical trials without having to travel outside their region,” said Dr. Vincent Barrette, Hemato-Oncologist at the CISSS de Chaudière-Appalaches.

Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines

Breast Cancer Canada proudly celebrates the federal government’s response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and

Queens Park: Breast Cancer Canada Calls on Ontarians

Self-Refer for Mammograms as Screening Age Lowers to 40 This pivotal change expands access to life-saving mammograms for millions of women in Ontario, empowering them

Cortney & Connie: Twin sisters carrying the BRCA2 Gene

This year alone, more than 30,000 Canadians are expected to be diagnosed with breast cancer. My journey began in 2015, when I was just 29

Manitoba removing barriers for breast screening

Manitoba is taking a significant step forward in breast cancer care with a new plan to lower the age for self-referral mammogram screenings. Currently, women

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.